Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro.
The DOI matches its Crossref record.
Abstract
Clara cell protein (CC-16, also designated CC-10) is synthesized by the bronchiolar epithelium and has been suggested as an inhibitor of phospholipase A2 (PLA2) activity. Therefore, CC-16 is a candidate for controlling inflammatory events in the lung. Because CC-16 amounts and function may be altered in fibrosing lung diseases in which bronchiolar injury has been reported, it was measured in alveolar fluids and sera. Secretory PLA2 activity in alveolar fluids and the influence of CC-16 on platelet-derived growth factor-induced human fibroblast chemotaxis and cytosolic PLA2 activity were also explored. CC-16 content was decreased in alveolar fluids from idiopathic pulmonary fibrosis (IPF: 1.3 +/- 0.1 mg/L) and bleomycin lung (1.1 +/- 0.2 versus 2.1 +/- 0.2 mg/L in controls, p < 0.05), whereas there was a three- to ninefold increase in secretory PLA2 activity (p < 0.05 versus controls). CC-16 inhibited fibroblast chemotaxis in a dose-dependent manner (90% inhibition at 30 micrograms/ml CC-16). This inhibition was reversed by reducing CC-16. CC-16 was also able to lower fibroblastic cytosolic PLA2 activity by 50% in vitro. In summary, CC-16 is able to inhibit fibroblast chemotaxis in vitro by mechanisms that may be related to a blockage of cytosolic PLA2 activity. It can be postulated that CC-16 deficiency may contribute to fibroblast burden activity in fibrosing lung diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Inhaled particles and lung cancer. Part A: Mechanisms
Knaapen, A. M., Borm, P. J. A., Albrecht, C., & Schins, R. P. F. (2004) · International Journal of Cancer · doi:10.1002/ijc.11708 · Cited by 606
Lung Epithelium–specific Proteins: Characteristics and Potential Applications as Markers
HERMANS, C., & BERNARD, A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.2.9806064 · Cited by 428
Self-citationVandevyver, S., Dejager, L., Tuckermann, J., & Libert, C. (2013) · Endocrinology · doi:10.1210/en.2012-2045 · Cited by 296
Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker
Broeckaert, & Bernard (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00760.x · Cited by 266
SIENRA-MONGE, J. J., RAMIREZ-AGUILAR, M., MORENO-MACIAS, H., REYES-RUIZ, N. I., DEL RÍO-NAVARRO, B. E., RUIZ-NAVARRO, M. X., HATCH, G., CRISSMAN, K., SLADE, R., DEVLIN, R. B., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02606.x · Cited by 99
Metadata
- Authors
- Lesur, O., Bernard, A., Arsalane, K., Lauwerys, R., Bégin, R., Cantin, A., & Lane, D.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-07
- Volume
- 152
- Issue
- 1
- Pages
- 290-297
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2003983452
- Cited by
- 140
- References
- 0
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. https://app.cochat.ai/papers/10.1164/ajrccm.152.1.7541278
- The paper
- Lesur, O., Bernard, A., Arsalane, K., Lauwerys, R., Bégin, R., Cantin, A., & Lane, D. (1995). Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.152.1.7541278
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.